Basit öğe kaydını göster

Hyperhomocysteinemia in patients with arterial occlusive disease

dc.contributor.authorBASAR, Yeliz
dc.contributor.authorAKSOY, M
dc.contributor.authorAYALP, K
dc.contributor.authorDILEGE, S
dc.contributor.authorBAKTIROGLU, S
dc.contributor.authorKURTOGLU, MEHMET HAMDİ
dc.contributor.authorSalmayenli, Nihal
dc.contributor.authorGENC, Fatih Ata
dc.contributor.authorKAYABALI, Murat
dc.date.accessioned2021-03-04T17:56:14Z
dc.date.available2021-03-04T17:56:14Z
dc.date.issued2006
dc.identifier.citationAKSOY M., BASAR Y., Salmayenli N., AYALP K., GENC F. A. , DILEGE S., KAYABALI M., BAKTIROGLU S., KURTOGLU M. H. , "Hyperhomocysteinemia in patients with arterial occlusive disease", SURGERY TODAY, cilt.36, ss.327-331, 2006
dc.identifier.issn0941-1291
dc.identifier.otherav_8811c6f6-c205-4a2d-8e60-5b059557003c
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/92371
dc.identifier.urihttps://doi.org/10.1007/s00595-005-3152-y
dc.description.abstractPurpose:Hyperhomocysteinemia (HHCA) is defined as an independent risk factor for atherothrombotic vascular disease; therefore, screening for HHCA is recommended. However, the incidence and characteristics of HHCA in patients with vascular disease remain unclear. We conducted this study in an attempt to resolve these issues.
dc.language.isoeng
dc.subjectKlinik Tıp (MED)
dc.subjectTıp
dc.subjectCERRAHİ
dc.subjectCerrahi Tıp Bilimleri
dc.subjectSağlık Bilimleri
dc.subjectKlinik Tıp
dc.titleHyperhomocysteinemia in patients with arterial occlusive disease
dc.typeMakale
dc.relation.journalSURGERY TODAY
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume36
dc.identifier.issue4
dc.identifier.startpage327
dc.identifier.endpage331
dc.contributor.firstauthorID22771


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster